From Reform to Implementation: Mexico Goes Live, Brazil Scales, and Colombia Heads Into Transition

Latin America's clinical research narrative is shifting from announcement to execution. Mexico has moved its 30-day authorization pathway into operational reality, Brazil's anuencia queue is producing volume signals, Colombia's device-trial transparency picture is complete, and Argentina is layering harmonization on top of investment scale.

Mexico · Brazil · Colombia · Argentina · COFEPRIS · ANVISA · INVIMA · ANMAT

See the full edition on LinkedIn: https://www.linkedin.com/pulse/7475138788793696256/ -- and on the Daily.ai archive: https://subscribe.bioaccessla.com/archive/4124196-Your-Newsletter279440

← All Global Trial Accelerators editions · Contact bioaccess®